Verified earnings results
ADMA Biologics Q3 2026 Earnings Results
Direct answer
ADMA Biologics reported Q3 2026 results on November 4, 2026.
Revenue was 141,100,000. EPS beat the estimate by 10.61%.
The result is verified against Verified earnings source.
Verified earnings source
Get free ADMA Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- November 4, 2026
- Reported timing
- After the US market closes
- EPS estimate
- 0.1989
- Reported EPS
- 0.22
- Revenue
- 141,100,000
- EPS surprise
- EPS beat the estimate by 10.61%.
Explore related company data
Read the frequently asked questions.
When did ADMA Biologics report Q3 2026 earnings?
ADMA Biologics reported on November 4, 2026. The reported timing was after the us market closes.
What is the available EPS estimate for ADMA Biologics?
The verified record provides an EPS estimate of 0.1989.
Has ADMA Biologics reported the Q3 2026 result?
Revenue was 141,100,000. EPS beat the estimate by 10.61%.
Which source supports this ADMA Biologics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.